10 Oct 2017

Tennis Anti-Doping Programme issues Quarterly Report

News Article

Tennis Anti-Doping Programme

On behalf of the seven stakeholders in the Tennis Anti-Doping Programme (TADP), the ITF releases the second quarterly TADP report. These reports provide a regular source of up-to-date information on the TADP to interested parties. This report contains information relating to Quarter 3 (July – September) of the 2017 TADP and includes year-to-date information from 2017 and full-year information from 2016 for reference.

In this report:

1. 2018 WADA Prohibited List.
2. Education – ITF Knowledge launched.
3. Warning – Higenamine.
4. Statistics for Quarter 3.
5. Analysis of Athlete Biological Passport Samples.
6. Decisions since the last report.

Editor’s note:

The Tennis Anti-Doping Programme applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed under the Programme in compliance with the requirements of the World Anti-Doping Code. More information on the Programme, sanctions, statistics, and related matters can be found at www.itftennis.com/antidoping.